125
Views
7
CrossRef citations to date
0
Altmetric
Investigación Original

Inicio de acciɃn de indacaterol en pacientes con EPOC: comparaciɃn con salbutamol y con la asociaciɃn de salmeterol y fluticasona

, , , , , & show all
Pages 311-318 | Published online: 06 Sep 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

W. Tatiana Garzon-Siatoya, Ismael Carrillo-Martin, Sergio E Chiarella & Alexei Gonzalez-Estrada. (2022) State-of-the-art beta-adrenoreceptor agonists for the treatment of asthma. Expert Opinion on Pharmacotherapy 23:2, pages 243-254.
Read now
Kai Michael Beeh, Anne-Marie Kirsten, Ana-Maria Tanase, Alexia Richard, Weihua Cao, Bettina Hederer, Jutta Beier, Oliver Kornmann & Richard N van Zyl-Smit. (2018) Indacaterol acetate/mometasone furoate provides sustained improvements in lung function compared with salmeterol xinafoate/fluticasone propionate in patients with moderate-to-very-severe COPD: results from a Phase II randomized, double-blind 12-week study. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 3923-3936.
Read now
Takeshi Ohno, Shota Wada, Souichirou Hanada, Hirochiyo Sawaguchi, Masato Muraki & Yuji Tohda. (2014) Efficacy of indacaterol on quality of life and pulmonary function in patients with COPD and inhaler device preferences. International Journal of Chronic Obstructive Pulmonary Disease 9, pages 107-114.
Read now
Andrea Rossi & Guido Polese. (2013) Indacaterol: a comprehensive review. International Journal of Chronic Obstructive Pulmonary Disease 8, pages 353-363.
Read now
Anthony D'Urzo & Claus Vogelmeier. (2012) Future of chronic obstructive pulmonary disease management. Expert Review of Respiratory Medicine 6:3, pages 285-299.
Read now
Paschalis Steiropoulos, Nikolaos Papanas, Evangelia Nena & Demosthenes Bouros. (2012) Indacaterol: a new long-acting β2-agonist in the management of chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 13:7, pages 1015-1029.
Read now

Articles from other publishers (1)

Girolamo Pelaia, Rosario Maselli & Maria Gabriella Matera. (2014) Treatment of Chronic Obstructive Pulmonary Disease by Dual Bronchodilation with Coformulation of Indacaterol/Glycopyrronium. Pharmacology 94:5-6, pages 249-258.
Crossref